Skip to main content

Dr James H. Sabry

CV as per end of term

Portrait of James Sabry
About RocheOur leadership team
View all leaders
Zur deutschen Version

Personal Data

Nationality
Canada, US

Year of Birth
1958

Education

1983
Queen’s University, Kingston, Canada, M.D

1989
California Institute of Technology, Pasadena, Biology, M.Sc.

1994
University of California, San Francisco, Neuroscience, Ph.D.

1994–1998
Stanford University, Biochemistry, Postdoctoral fellow

Professional experience

1984-1987
Harvard Medical School, Resident in Neurology

1987
Harvard Medical School, Chief Resident in Neurology

1989–1998
University of California, San Francisco, Adjunct Clinical Appointment in the Department of Neurology

1997–2006
Cytokinetics, Co-founder, President  and CEO

2008–2010
Arete Therapeutics, President and CEO

2010–2013
Genentech Partnering, Global Head and Vice President

2013–2018
Genentech Partnering, Global Head and Senior Vice President

Since 2018
Roche Basel, Global Head of Pharma Partnering

Present external mandates

in listed companies

in unlisted companies

Other activities / non-profit activities / memberships

Since 1998
Member of Scientific Advisory Board at Cytokinetics

2005–2016
Member of the Board of Directors of HopeLab

2007–2008
Executive Chairman of the Board of Directors of Cytokinetics

2008–2010
Chairman of the Board of Directors of Cytokinetics

2015–2016
Member of the Board of Directors of California Life Sciences Association

2016–2020
Member of the Board of Directors of Coalition for the Life Sciences

Since 2019
Member of the Board of Directors, Chugai Pharmaceutical Co., Ltd

Awards / Honors


Möchten Sie den Inhalt auf Deutsch lesen?

Discover more

  • Board of Directors

    About Roche

    The Board of Directors' composition and the curricula vitae of its members.

  • Executive Committee

    About Roche

    The Executive Committee's composition and the curricula vitae of its members.

  • Annual General Meeting

    About Roche

    The General Meeting is convened by the Board of Directors, together with its agenda and the proposals of the Board of Directors and the shareholders.

  • Board Committees

    About Roche

    Our Board of Directors has delegated certain matters to four committees for detailed attention.

  • Code of conduct

    About Roche

    The Roche Group Code of Conduct states the expectations Roche as an employer has towards his employees and sets forth the standards for business behaviour that apply throughout the Roche Group.

  • Investors

    Investors

    We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.